MANETTI FABRIZIO

Fabrizio
Manetti
Professore Ordinario

Office hours

  • Wednesday from 10:00 to 12:00
    Place: Studio del docente - Polo Scientifico Universitario di San Miniato
    Note: Previo appuntamento da concordare a mezzo e-mail

Curriculum Vitae

Teaching activities

Completion accademic year: 2024/2025

Course year: 2 Full cicle (5 years) CHIMICA E TECNOLOGIA FARMACEUTICHE A.Y. 2023/2024
Course year: 2 Full cicle (5 years) CHIMICA E TECNOLOGIA FARMACEUTICHE A.Y. 2023/2024
Course year: 2 Full cicle (5 years) CHIMICA E TECNOLOGIA FARMACEUTICHE A.Y. 2023/2024

Completion accademic year: 2023/2024

Course year: 2 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2022/2023
Course year: 2 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2022/2023
Course year: 2 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2022/2023

Completion accademic year: 2022/2023

Course year: 2 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2021/2022
Course year: 2 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2021/2022
Course year: 2 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2021/2022

Completion accademic year: 2021/2022

Course year: 2 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2020/2021

Research

Ultime pubblicazioni:

  • Governa, P., Biagi, M., Manetti, F., Forli, S. (2024). Consensus screening for a challenging target: the quest for P-glycoprotein inhibitors. RSC MEDICINAL CHEMISTRY, 15(2), 720-732 [10.1039/d3md00649b]. - view more
  • Gori Savellini, G., Anichini, G., Manetti, F., Trivisani, C.I., Cusi, M.G. (2024). Deletion of 82–85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication. VIRUSES, 16(5) [10.3390/v16050689]. - view more
  • Vagaggini, C., Petroni, D., D'Agostino, I., Poggialini, F., Cavallini, C., Cianciusi, A., et al. (2024). Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment. DRUG DEVELOPMENT RESEARCH, 85(1), 1-13 [10.1002/ddr.22158]. - view more
  • Tamburello, M., Salamone, S., Anceschi, L., Governa, P., Brighenti, V., Morellini, A., et al. (2023). Antiviral activity of cannabidiolic acid and its methyl ester against SARS-CoV-2. JOURNAL OF NATURAL PRODUCTS, 86(7), 1698-1707 [10.1021/acs.jnatprod.3c00111]. - view more
  • Degiacomi, G., Gianibbi, B., Recchia, D., Stelitano, G., Truglio, G.i., Marra, P., et al. (2023). CanB, a druggable cellular target in mycobacterium tuberculosis. ACS OMEGA, 8(28), 25209-25220 [10.1021/acsomega.3c02311]. - view more